Cross Country Healthcare (CCRN) Misses Q2 EPS by 3c ; Offers Guidance
Tweet
Share
E-mailGet Alerts CCRN Hot Sheet
Price: $13.21 --0%
EPS Growth %: +200.0%
Financial Fact:
Total operating expenses: 205.66M
Today's EPS Names:
STZ, NKE, PRGS, More
EPS Growth %: +200.0%
Financial Fact:
Total operating expenses: 205.66M
Today's EPS Names:
STZ, NKE, PRGS, More
Join SI Premium – FREE
Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of $0.10, $0.03 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $339.77 million versus the consensus estimate of $334.75 million.
GUIDANCE:
Cross Country Healthcare sees Q3 2024 EPS of $0.08-$0.12, versus the consensus of $0.17. Cross Country Healthcare sees Q3 2024 revenue of $305-315 million, versus the consensus of $330.9 million.
For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- Barclays Starts Hawkins (HWKN) at Equalweight
- Expedia (EXPE) PT Lowered to $303 at Wells Fargo
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
